Stockscreener 앱 받기
3.8448
1.91%
-0.0752
Ataibeckley Inc 주식(ATAI)의 최신 뉴스
ATAI: Advancing late-stage psychedelics for depression with key data readouts and strong financial runway - TradingView
ATAI: Advancing late-stage psychedelics for mental health, with key phase III and II-B trials underway - TradingView
Is AtaiBeckley Inc. (ATAI) the Hidden Penny Stock to Invest In? - Yahoo Finance
AtaiBeckley Inc. (ATAI) Holds Above Key Support, Posts Modest GainTrend Continuation Trade - newsline.com
ATAIBECKLEY INC. Files Form 8-K with SEC: Company Details, Stock Information, and NASDAQ Listing - Minichart
H.C. Wainwright reiterates Buy on Atai stock, $25 target By Investing.com - Investing.com Australia
AtaiBeckley Inc. (ATAI) awards 121,968 stock options to director - Stock Titan
AtaiBeckley Inc. (ATAI) director granted 121,968 stock options at $4.50 - Stock Titan
AtaiBeckley (ATAI) grants director 121,968 stock options at $4.50 - Stock Titan
AtaiBeckley (NASDAQ: ATAI) shareholders back board slate and Deloitte as 2026 auditor - Stock Titan
H.C. Wainwright reiterates Buy on Atai stock, $25 target - Investing.com UK
Atai Beckley N.V. (ATAI) A Top Penny Stock to Buy Poised to Build Sustained Clinical and Shareholder Value - Yahoo Finance
ATAI Q1 2026 Earnings: Narrower Loss Beats Estimates, Stock Declines Amid Market VolatilityEarnings Quality Score - newsline.com
AtaiBeckley (ATAI) Among the Best Penny Stocks with Huge Upside Potential - Insider Monkey
AtaiBeckley (ATAI) Drops Over 12%: Testing Key Support at $3.75Value Stock Ideas - newsline.com
5 Best Penny Stocks with Huge Upside Potential - Insider Monkey
Small cap wrap: Gunnison Copper, Trillion Energy, AtaiBeckley… - Proactive financial news
AtaiBeckley nears key clinical catalysts, Jefferies stays positive with repeat ‘Buy’ rating - Yahoo! Finance Canada
Is AtaiBeckley’s BPL-003 Phase 3 Launch Altering The Investment Case For AtaiBeckley (ATAI)? - Yahoo Finance
Jefferies reiterates atai Life Sciences stock rating on pipeline progress - Investing.com
Assessing AtaiBeckley (ATAI) Valuation After Strong Returns And Elevated Price To Book Ratio - Yahoo Finance
Is AtaiBeckley (ATAI) Using BPL-003’s Phase 3 Launch to Redefine Its Risk‑Reward Profile? - simplywall.st
ATAI: BPL-003 enters phase III for depression, with top-line data expected in early 2029 - TradingView
ATAI: BPL-003 phase III for depression begins, with VLS-01 phase IIb results due Q4 2024 - TradingView
AtaiBeckley to discuss Phase 3 BPL-003 program at multiple June investor conferences - TradingView
AtaiBeckley (NASDAQ: ATAI) to present BPL-003 Phase 3 updates - Stock Titan
ATAI Q1 2026 Earnings: Narrower Than Expected Loss Drives Positive Surprise Despite Modest Stock Decline - newsline.com
AtaiBeckley Grant Program Links Mental Health Impact With Investor Considerations - Sahm
ATAI Q1 2026 Earnings: Narrower Loss Beats Estimates; Stock Edges HigherEarnings Weakness Phase - thelegaladvocate.com
AtaiBeckley Launches Patient Impact Grant Program for Mental Health Non-Profit Organizations - Investing News Network
Small cap wrap: AtaiBeckley, Medicus Pharma, Bit Digital, American Resources, Nextech3D.ai… - Proactive financial news
AtaiBeckley launches mental health patient impact grant program - Proactive financial news
New $20,000 mental health grants for nonprofits now open for applications - Stock Titan
AtaiBeckley to present at multiple investor conferences in June 2026, highlighting its mental health drug pipeline. - Pluang
AtaiBeckley to Participate in Upcoming Investor Conferences in June 2026 - Investing News Network
AtaiBeckley to participate in multiple June investor conferences - Proactive financial news
AtaiBeckley Inc. Cash Flow – HAM:B72 - TradingView
Total debt of AtaiBeckley Inc. – HAM:B72 - TradingView
AtaiBeckley Inc. Balance Sheet – HAM:B72 - TradingView
Return on assets % of AtaiBeckley Inc. – HAM:B72 - TradingView
AtaiBeckley Inc. Trade Ideas — HAM:B72 - TradingView
ATAI Q1 2026 Earnings: Narrower-Than-Expected Loss Fails to Lift SharesInterim Report - newsline.com
ATAI Q1 2026 Earnings: Narrower-than-Expected Loss as Clinical Pipeline AdvancesRevenue Beat Analysis - newsline.com
AtaiBeckley (ATAI) Reports Q1 Financial Results - Insider Monkey
AtaiBeckley Inc. (ATAI) Surges 5.87%: Testing Key Resistance LevelsDip Buy Trade - The Legal Advocate
10 Best Penny Stocks to Buy for Long Term - Insider Monkey
These stocks are today’s movers: Fermi, AST SpaceMobile, Intel, Marvell, USA Rare Earth, Ataibeckley, and more - MSN
AtaiBeckley Inc. (NASDAQ: ATAI): Advancing Psychedelic Mental Health Therapies with Clinical Momentum - Kalkine
How AtaiBeckley’s Wider Q1 Loss But Lower Per-Share Hit At AtaiBeckley (ATAI) Has Changed Its Investment Story - simplywall.st
Trump's psychedelic drug order boosts investor interest with promise of faster reviews - marketscreener.com
A Look At AtaiBeckley (ATAI) Valuation As Share Price Momentum And DCF Signal Differ - Yahoo Finance
0.12%
자본화:
|
볼륨(24시간):